Table 5.
Dosimetric parameters of clinical target volume-IIa in all plans
| Plans | Dmean (Gy) | Dmax (Gy) | Dmin (Gy) | V60 | p1 | p2 | p3 | p4 | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| A | 63.7 ± 0.8 | 67.7 ± 1.9 | 59.9 ± 1.5 | 99.9 | – | – | – | – | ||||||||||||
| B | 63.5 ± 0.2 | 71.1 ± 3.6 | 44.4 ± 4.3 | 88.2 | 0.24 | 0.03 | 0.02 | <0.01 | ||||||||||||
| C | 63.7 ± 0.7 | 67.9 ± 1.7 | 57.5 ± 2.9 | 99.5 | 0.17 | 0.80 | 0.35 | 0.82 | ||||||||||||
| D | 63.7 ± 0.6 | 67.9 ± 1.8 | 56.6 ± 2.4 | 95.3 | 0.11 | 0.87 | 0.48 | 0.04 |
Dmax, maximum point dose; Dmean, mean dose; Dmin, minimum point dose; p1, Dmean compared to plan A; p2, Dmin compared to plan A; p3, Dmax compared to plan A; p4, V60 compared to plan A; V60, percentage of the volume covered by the dose of 60 Gy.
Data shown as ± standard deviation.